Skip to main content

Liver-Targeted Gene Delivery Through Retrograde Intrabiliary Infusion

  • Protocol
  • First Online:
Nanotechnology for Nucleic Acid Delivery

Part of the book series: Methods in Molecular Biology ((MIMB,volume 948))

Abstract

Retrograde intrabiliary infusion (RII) has recently been characterized as a safe and effective administration route for liver-targeted gene delivery. Efficient transgene expression in the liver has been achieved by infusing a variety of gene vectors including adenovirus, retrovirus, lipoplexes, polyplexes, and naked DNA through the common bile duct. Here, we describe the RII technique and key infusion parameters for delivering plasmid DNA and DNA nanoparticles to the rat liver. After RII of plasmid DNA, the level of transgene expression in rat liver is comparable to that achieved by hydrodynamic injection of plasmid DNA, which is considered to be “gold standard” for liver-targeted gene delivery. RII has also been shown to significantly enhance the gene delivery efficiency by polymer/DNA nanoparticles in comparison with intravenous and intraportal infusions. This method induces minimal level of cytotoxicity and damage to the liver and bile duct. Due to these advantages, RII has the potential to be used for delivering various gene vectors in clinical setting through the endoscopic retrograde cholangiopancreatography procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nguyen TH, Ferry N (2004) Liver gene therapy: advances and hurdles. Gene Ther 11:S76–S84

    Article  CAS  Google Scholar 

  2. Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ (2002) Gene therapy as an alternative to liver transplantation. Liver Transpl 8:1089–1108

    Article  Google Scholar 

  3. Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, Ruiz J (2003) The promise of gene therapy in gastrointestinal and liver diseases. Gut 52:ii49–ii54

    Article  CAS  Google Scholar 

  4. Cristiano RJ, Smith LC, Kay MA, Brinkley BR, Woo SLC (1993) Hepatic gene-therapy - efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci USA 90:11548–11552

    Article  CAS  Google Scholar 

  5. Nathwani AC, Davidoff AM, Hanawa H, Hu YN, Hoffer FA, Nikanorov A, Slaughter C, Ng CYC, Zhou JF, Lozier JN, Mandrell TD, Vanin EF, Nienhuis AW (2002) Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood 100:1662–1669

    Article  CAS  Google Scholar 

  6. Cheung ST, Tsui TY, Wang WL, Yang ZF, Wong SY, Ip YC, Luk J, Fan ST (2002) Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer. J Gastroenterol Hepatol 17:1008–1014

    Article  CAS  Google Scholar 

  7. Jooss K, Chirmule N (2003) Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther 10:955–963

    Article  CAS  Google Scholar 

  8. Cichon G, Schmidt HH, Benhidjeb T, Loser P, Ziemer S, Haas R, Grewe N, Schnieders F, Heeren J, Manns MP, Schlag PM, Strauss M (1999) Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1:360–371

    Article  CAS  Google Scholar 

  9. Treco DA, Selden RF (1995) Nonviral gene-therapy. Mol Med Today 1:314–321

    Article  CAS  Google Scholar 

  10. Herweijer H, Wolff JA (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10:453–458

    Article  CAS  Google Scholar 

  11. Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647–1652

    Article  CAS  Google Scholar 

  12. Kawakami S, Yamashita F, Nishida K, Nakamura J, Hashida M (2002) Glycosylated cationic Liposomes for cell-selective gene delivery. Crit Rev Ther Drug Carrier Syst 19:171–190

    Article  CAS  Google Scholar 

  13. Rogers JV, Bigley NJ, Chiou HC, Hull BE (2000) Targeted delivery of DNA encoding herpes simplex virus type-1 glycoprotein D enhances the cellular response to primary viral challenge. Arch Dermatol Res 292:542–549

    Article  CAS  Google Scholar 

  14. Reichen J (1999) The role of the sinusoidal endothelium in liver function. News Physiol Sci 14:117–121

    Google Scholar 

  15. Otsuka M, Baru M, Delriviere L, Talpe S, Nur I, Gianello P (2000) In vivo liver-directed gene transfer in rats and pigs with large anionic multilamellar liposomes: routes of administration and effects of surgical manipulations on transfection efficiency. J Drug Target 8:267–279

    Article  CAS  Google Scholar 

  16. Zakim D, Boyer TD (2003) Hepatology: a textbook of liver disease. Saunders, Philadelphia

    Google Scholar 

  17. Ludwig J, Ritman EL, LaRusso NF, Sheedy PF, Zumpe G (1998) Anatomy of the human biliary system studied by quantitative computer-aided three-dimensional imaging techniques. Hepatology 27:893–899

    Article  CAS  Google Scholar 

  18. Bircher J (1999) Oxford textbook of clinical hepatology. Oxford University Press, Oxford

    Google Scholar 

  19. Zhang XH, Collins L, Sawyer GJ, Dong XB, Qiu Y, Fabre JW (2001) In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine. Hum Gene Ther 12:2179–2190

    Article  CAS  Google Scholar 

  20. Xie X, Forsmark CE, Lau JYN (1997) Feasibility of adenoviral-mediated gene delivery through ERCP - the effect or bile and pancreatic juice. Hepatology 26:276–276

    Google Scholar 

  21. Xie XM, Forsmark CE, Lau JYN (2000) Effect of bile and pancreatic juice on adenoviral-mediated gene delivery - implications on the feasibility of gene delivery through ERCP. Dig Dis Sci 45:230–236

    Article  CAS  Google Scholar 

  22. Tominaga K, Kuriyama S, Yoshiji H, Deguchi A, Kita Y, Funakoshi F, Masaki T, Kurokohchi K, Uchida N, Tsujimoto T, Fukui H (2004) Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies. Gut 53:1167–1173

    Article  CAS  Google Scholar 

  23. Dai H, Jiang X, Tan GC, Chen Y, Torbenson M, Leong KW, Mao HQ (2006) Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine 1:507–522

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hai-Quan Mao .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Jiang, X., Ren, Y., Williford, JM., Li, Z., Mao, HQ. (2013). Liver-Targeted Gene Delivery Through Retrograde Intrabiliary Infusion. In: Ogris, M., Oupicky, D. (eds) Nanotechnology for Nucleic Acid Delivery. Methods in Molecular Biology, vol 948. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-140-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-140-0_19

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-139-4

  • Online ISBN: 978-1-62703-140-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics